公司資料
COMPASS Pathways Plc 股價、新聞與催化劑
- 股票代碼:
- CMPS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom
股票表現
14.20 USD (+6.53%)
收盤價
最後更新: 2026年8月24日
1.8B USD
市值
股價為何變動
As of Aug 24, 2026, CMPS closed up 6.53% at $14.20. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
COMPASS Pathways is a neuroscience company focused on psychedelic-assisted therapy and depression. Its story is centered on whether a novel mental-health paradigm can be translated into regulated medicine.
所在地與產業分類
Headquartered in the United Kingdom and listed on NASDAQ as an ADR, COMPASS sits in specialty neuroscience biotechnology.
商業模式特徵
The company depends on clinical data, regulatory progress, and the commercial viability of a new treatment model for depression.
生技產業定位
COMPASS is a high-catalyst CNS name whose value is heavily tied to clinical and regulatory outcomes.
未來催化劑
- Compass Pathways’s key catalyst is COMP360 in treatment-resistant depression, with the next clinical and regulatory steps doing most of the work. The market will react quickly if the psilocybin story keeps building toward a viable commercial path.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。